Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice

Physiological Genomics

Volumn 48, Issue 9, 2016, Pages 667-676

  Wang, Lei ^a   Hiller, Helmut ^a   Smith, Justin A ^a   de Kloet, Annette D ^b   Krause, Eric G ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Anxiety; Corticosterone; Corticotropin releasing hormone; Neuroinflammation; Stress

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; CORTICOTROPIN RELEASING FACTOR; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR; ANGIOTENSIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ELEVATED PLUS MAZE TEST; ENCEPHALITIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART RATE; HEART RATE VARIABILITY; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMOBILIZATION STRESS; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYMPATHETIC FUNCTION; SYSTOLIC BLOOD PRESSURE; TELEMETRY; ADRENERGIC SYSTEM; ANIMAL; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; ANXIETY; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CORTICOTROPIN-RELEASING HORMONE; HEART RATE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, KNOCKOUT; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 84988632523     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00029.2016     Document Type: Article

References (75)

1. Agarwal D, Dange RB, Raizada MK, Francis J. Angiotensin II causes imbalance between pro- and anti-inflammatory cytokines by modulating GSK-3beta in neuronal culture. Br J Pharmacol 169: 860–874, 2013.
2. Aguilera G, Kiss A, Luo X. Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J Neuroendocrinol 7: 775–783, 1995.
3. Aguilera G, Young WS, Kiss A, Bathia A. Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II. Neuroendocrinology 61: 437–444, 1995.
4. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, McGovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B, Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK, Lowell BB. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123: 493–505, 2005.
5. Benicky J, Sanchez-Lemus E, Honda M, Pang T, Orecna M, Wang J, Leng Y, Chuang DM, Saavedra JM. Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology 36: 857–870, 2011.
6. Biancardi VC, Son SJ, Ahmadi S, Filosa JA, Stern JE. Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier. Hypertension 63: 572–579, 2014.
7. Blandino P Jr, Barnum CJ, Deak T. The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1beta responses to stress. J Neuroimmunol 173: 87–95, 2006.
8. Blandino P Jr, Barnum CJ, Solomon LG, Larish Y, Lankow BS, Deak T. Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress. Brain Behav Immun 23: 958–968, 2009.
9. Braszko JJ, Karwowska-Polecka W, Halicka D, Gard PR. Captopril and enalapril improve cognition and depressed mood in hypertensive patients. J Basic Clin Physiol Pharmacol 14: 323–343, 2003.
10. Busnardo C, Tavares RF, Correa FM. Angiotensinergic neurotransmission in the paraventricular nucleus of the hypothalamus modulates the pressor response to acute restraint stress in rats. Neuroscience 270: 12–19, 2014.
11. Dantzer R. Cytokine, sickness behavior, depression. Neurol Clin 24: 441–460, 2006.
12. de Kloet AD, Krause EG, Scott KA, Foster MT, Herman JP, Sakai RR, Seeley RJ, Woods SC. Central angiotensin II has catabolic action at white and brown adipose tissue. Am J Physiol Endocrinol Metab 301: E1081–E1091, 2011.
13. de Kloet AD, Liu M, Rodriguez V, Krause EG, Sumners C. Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control. Am J Physiol Regul Integr Comp Physiol 309: R444–R458, 2015.
14. de Kloet AD, Pati D, Wang L, Hiller H, Sumners C, Frazier CJ, Seeley RJ, Herman JP, Woods SC, Krause EG. Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against dietinduced obesity. J Neurosci 33: 4825–4833, 2013.
15. de Kloet AD, Wang L, Ludin JA, Smith JA, Pioquinto DJ, Hiller H, Steckelings UM, Scheuer DA, Sumners C, Krause EG. Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system. Brain Struct Funct 221: 891–912, 2016.
16. de Kloet ER. Hormones, brain and stress. Endocr Regul 37: 51–68, 2003.
17. Dopp JM, Mackenzie-Graham A, Otero GC, Merrill JE. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 75: 104–112, 1997.
18. Duan SZ, Christe M, Milstone DS, Mortensen RM. Go but not Gi2 or Gi3 is required for muscarinic regulation of heart rate and heart rate variability in mice. Biochem Biophys Res Commun 357: 139–143, 2007.
19. Dunn AJ. Cytokine activation of the HPA axis. Ann NY Acad Sci 917: 608–617, 2000.
20. Faravelli C, Lo Sauro C, Lelli L, Pietrini F, Lazzeretti L, Godini L, Benni L, Fioravanti G, Talamba GA, Castellini G, Ricca V. The role of life events and HPA axis in anxiety disorders: a review. Curr Pharmaceut Design 18: 5663–5674, 2012.
21. File SE, Johnston AL, Baldwin HA. Anxiolytic and anxiogenic drugs - changes in behavior and endocrine responses. Stress Med 4: 221–230, 1988.
22. Fry M, Ferguson AV. The sensory circumventricular organs: brain targets for circulating signals controlling ingestive behavior. Physiol Behav 91: 413–423, 2007.
23. Fyffe SL, Neul JL, Samaco RC, Chao HT, Ben-Shachar S, Moretti P, McGill BE, Goulding EH, Sullivan E, Tecott LH, Zoghbi HY. Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 59: 947–958, 2008.
24. Gadek-Michalska A, Tadeusz J, Rachwalska P, Spyrka J, Bugajski J. Brain nitric oxide synthases in the interleukin-1beta-induced activation of hypothalamic-pituitary-adrenal axis. Pharmacol Rep 64: 1455–1465, 2012.
25. Gonzalez AD, Wang G, Waters EM, Gonzales KL, Speth RC, Van Kempen TA, Marques-Lopes J, Young CN, Butler SD, Davisson RL, Iadecola C, Pickel VM, Pierce JP, Milner TA. Distribution of angio- tensin type 1a receptor-containing cells in the brains of bacterial artificial chromosome transgenic mice. Neuroscience 226: 489–509, 2012.
26. Gutman DA, Owens MJ, Skelton KH, Thrivikraman KV, Nemeroff CB. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J Pharmacol Exp Therapeut 304: 874–880, 2003.
27. Haarman BC, Riemersma-Van der Lek RF, de Groot JC, Ruhe HG, Klein HC, Zandstra TE, Burger H, Schoevers RA, de Vries EF, Drexhage HA, Nolen WA, Doorduin J. Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study. Brain Behav Immun 40: 219–225, 2014.
28. Heinrichs SC, De Souza EB, Schulteis G, Lapsansky JL, Grigoriadis DE. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist. Neuropsychopharmacology 27: 194–202, 2002.
29. Herman JP, Cullinan WE. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20: 78– 84, 1997.
30. Hou RH, Baldwin DS. A neuroimmunological perspective on anxiety disorders. Hum Psychopharm Clin 27: 6–14, 2012.
31. Hurt RC, Garrett JC, Keifer OP Jr, Linares A, Couling L, Speth RC, Ressler KJ, Marvar PJ. Angiotensin type 1a receptors on corticotropinreleasing factor neurons contribute to the expression of conditioned fear. Genes Brain Behav 14: 526–533, 2015.
32. Jarrett B, Godbout J, McKim D, Sheridan J. Minocycline attenuates stress-induced changes in leukocyte activation and anxiety-like behavior. Brain Behav Immun 40, Suppl: e23–e24, 2014.
33. Jezova D, Ochedalski T, Kiss A, Aguilera G. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J Neuroendocrinol 10: 67–72, 1998.
34. Karson A, Demirtas T, Bayramgurler D, Balci F, Utkan T. Chronic administration of infliximab (TNF-alpha inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic Clin Pharmacol Toxicol 112: 335–340, 2013.
35. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617–627, 2005.
36. Khoury NM, Marvar PJ, Gillespie CF, Wingo A, Schwartz A, Bradley B, Kramer M, Ressler KJ. The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J Clin Psychiatry 73: 849–855, 2012.
37. Krause EG, de Kloet AD, Flak JN, Smeltzer MD, Solomon MB, Evanson NK, Woods SC, Sakai RR, Herman JP. Hydration state controls stress responsiveness and social behavior. J Neurosci 31: 5470–5476, 2011.
38. Krause EG, de Kloet AD, Scott KA, Flak JN, Jones K, Smeltzer MD, Ulrich-Lai YM, Woods SC, Wilson SP, Reagan LP, Herman JP, Sakai RR. Blood-borne angiotensin II acts in the brain to influence behavioral and endocrine responses to psychogenic stress. J Neurosci 31: 15009–15015, 2011.
39. Krause EG, Melhorn SJ, Davis JF, Scott KA, Ma LY, de Kloet AD, Benoit SC, Woods SC, Sakai RR. Angiotensin type 1 receptors in the subfornical organ mediate the drinking and hypothalamic-pituitary-adrenal response to systemic isoproterenol. Endocrinology 149: 6416–6424, 2008.
40. Kuno R, Wang JY, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. Autocrine activation of microglia by tumor necrosis factor-alpha. J Neuroimmunol 162: 89–96, 2005.
41. Kupferschmidt DA, Newman AE, Boonstra R, Erb S. Antagonism of cannabinoid 1 receptors reverses the anxiety-like behavior induced by central injections of corticotropin-releasing factor and cocaine withdrawal. Neuroscience 204: 125–133, 2012.
42. Leong DS, Terron JA, Falcon-Neri A, Armando I, Ito T, Johren O, Tonelli LH, Hoe KL, Saavedra JM. Restraint stress modulates brain, pituitary and adrenal expression of angiotensin II AT(1A), AT(1B) and AT(2) receptors. Neuroendocrinology 75: 227–240, 2002.
43. Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40: 171–176, 1999.
44. Mckinley MJ, Evered M, Mathai M, Coghlan JP. Effects of central losartan on plasma-renin and centrally mediated natriuresis. Kidney Int 46: 1479–1482, 1994.
45. McKinley MJ, McBurnie MI, Mathai ML. Neural mechanisms subserving central angiotensinergic influences on plasma renin in sheep. Hypertension 37: 1375–1381, 2001.
46. Michaud JL, Rosenquist T, May NR, Fan CM. Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1. Genes Dev 12: 3264–3275, 1998.
47. Miyoshi M, Miyano K, Moriyama N, Taniguchi M, Watanabe T. Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation. Eur J Neurosci 27: 343–351, 2008.
48. Morrison FG, Ressler KJ. From the neurobiology of extinction to improved clinical treatments. Depress Anxiety 31: 279–290, 2014.
49. Najjar S, Pearlman DM, Hirsch S, Friedman K, Strange J, Reidy J, Khoukaz M, Ferrell RB, Devinsky O, Najjar A, Zagzag D. Brain biopsy findings link major depressive disorder to neuroinflammation, oxidative stress, and neurovascular dysfunction: a case report. Biol Psychiatry 75: e23–26, 2014.
50. Neigh GN, Karelina K, Glasper ER, Bowers SLK, Zhang N, Popovich PG, DeVries AC. Anxiety after cardiac arrest/cardiopulmonary resuscitation exacerbated by stress and prevented by minocycline. Stroke 40: 3601–3607, 2009.
51. Nijsen MJ, Croiset G, Stam R, Bruijnzeel A, Diamant M, de Wied D, Wiegant VM. The role of the CRH type 1 receptor in autonomic responses to corticotropin- releasing hormone in the rat. Neuropsychopharmacology 22: 388–399, 2000.
52. Oldfield BJ, Davern PJ, Giles ME, Allen AM, Badoer E, McKinley MJ. Efferent neural projections of angiotensin receptor (AT1) expressing neurones in the hypothalamic paraventricular nucleus of the rat. J Neuroendocrinol 13: 139–146, 2001.
53. Pinteaux E, Parker LC, Rothwell NJ, Luheshi GN. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J Neurochem 83: 754–763, 2002.
54. Raasch W, Wittmershaus C, Dendorfer A, Voges I, Pahlke F, Dodt C, Dominiak P, Johren O. Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats. Endocrinology 147: 3539–3546, 2006.
55. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58: 445–452, 2001.
56. Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, Musella A, Barbieri F, Bari M, Bernardi G, Maccarrone M, Usiello A, Centonze D. Interleukin-1beta causes anxiety by interacting with the endocannabinoid system. J Neurosci 32: 13896–13905, 2012.
57. Roth WT, Doberenz S, Dietel A, Conrad A, Mueller A, Wollburg E, Meuret AE, Barr Taylor C, Kim S. Sympathetic activation in broadly defined generalized anxiety disorder. J Psychiatr Res 42: 205–212, 2008.
58. Ruyle BC, Callanan GF, Haney MM, Coldren KM, Heesch CM, Hasser EM. Localization of corticotropin releasing factor receptor 2 (CRFR2) in the nucleus tractus solitarii (nTS). FASEB J 30: 755.7, 2016.
59. Saavedra JM, Ando H, Armando I, Baiardi G, Bregonzio C, Juorio A, Macova M. Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Regul Pept 128: 227–238, 2005.
60. Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, Suridjan I, Kennedy JL, Rekkas PV, Houle S, Meyer JH. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72: 268–275, 2015.
61. Shi Z, Gan XB, Fan ZD, Zhang F, Zhou YB, Gao XY, De W, Zhu GQ. Inflammatory cytokines in paraventricular nucleus modulate sympathetic activity and cardiac sympathetic afferent reflex in rats. Acta Physiol (Oxf) 203: 289–297, 2011.
62. Smith JA, Wang L, Hiller H, Taylor CT, de Kloet AD, Krause EG. Acute hypernatremia promotes anxiolysis and attenuates stress-induced activation of the hypothalamic-pituitary-adrenal axis in male mice. Physiol Behav 136: 91–96, 2014.
63. Sugama S, Fujita M, Hashimoto M, Conti B. Stress induced morphological microglial activation in the rodent brain: involvement of interleukin- 18. Neuroscience 146: 1388–1399, 2007.
64. Takahashi H, Nishimura M, Sakamoto M, Ikegaki I, Nakanishi T, Yoshimura M. Effects of interleukin-1 beta on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats. Am J Hypertens 5: 224–229, 1992.
65. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19: 162–166, 1998.
66. van Gaalen MM, Stenzel-Poore MP, Holsboer F, Steckler T. Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur J Neurosci 15: 2007–2015, 2002.
67. van Houten M, Schiffrin EL, Mann JF, Posner BI, Boucher R. Radioautographic localization of specific binding sites for blood-borne angiotensin II in the rat brain. Brain Res 186: 480–485, 1980.
68. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428: 191–212, 2000.
69. Villapol S, Yaszemski AK, Logan TT, Sanchez-Lemus E, Saavedra JM, Symes AJ. Candesartan, an angiotensin II AT(1)-receptor blocker and PPAR-gamma agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice. Neuropsychopharmacology 37: 2817–2829, 2012.
70. Vogelzangs N, Beekman AT, de Jonge P, Penninx BW. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry 3: e249, 2013.
71. Wang L, de Kloet AD, Pati D, Hiller H, Smith JA, Pioquinto DJ, Ludin JA, Oh SP, Katovich MJ, Frazier CJ, Raizada MK, Krause EG. Increasing brain angiotensin converting enzyme 2 activity decreases anxiety- like behavior in male mice by activating central Mas receptors. Neuropharmacology 105: 114–123, 2016.
72. Williams TD, Chambers JB, Gagnon SP, Roberts LM, Henderson RP, Overton JM. Cardiovascular and metabolic responses to fasting and thermoneutrality in Ay mice. Physiol Behav 78: 615–623, 2003.
73. Yang G, Xi ZX, Wan Y, Wang H, Bi G. Changes in circulating and tissue angiotensin II during acute and chronic stress. Biol Signals 2: 166–172, 1993.
74. Yoshida S, Takeuchi T, Kotani T, Yamamoto N, Hata K, Nagai K, Shoda T, Takai S, Makino S, Hanafusa T. Infliximab, a TNF-alpha inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients. J Hum Hypertens 28: 165–169, 2014.
75. Zhu GQ, Patel KP, Zucker IH, Wang W. Microinjection of ANG II into paraventricular nucleus enhances cardiac sympathetic afferent reflex in rats. Am J Physiol Heart Circ Physiol 282: H2039–H2045, 2002.